Pure Global

COVID-19 Neutralizing Antibody ELISA Test - India CDSCO Medical Device Registration

COVID-19 Neutralizing Antibody ELISA Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2018/000029_e9850d71276ebb666bbd46a356eed0a0_3ec22b4d34ba9eb25d2fdefa250de89c. This device is marketed under the brand name Merilisa. The license holder is Meril Diagnostics Pvt. Ltd., and it is classified as Device Class Class C. The approving authority is Central Drug Standards Control Organization, Ahmedabad.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
COVID-19 Neutralizing Antibody ELISA Test
UID: MFG/MD/2018/000029_e9850d71276ebb666bbd46a356eed0a0_3ec22b4d34ba9eb25d2fdefa250de89c

Brand Name

Merilisa

Device Class

Class C

Approving Authority

Central Drug Standards Control Organization, Ahmedabad

Product Information

Covid - 19 Neutralizing Antibody Detection Kit is a blocking enzyme-linked immunosorbent assay intended for qualitative direct detection of total neutralizing antibodies to covid-19 in human serum and plasma

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing